A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Boundless Bio, Inc.
Memorial Sloan Kettering Cancer Center
University Health Network, Toronto
Children's National Research Institute
Fred Hutchinson Cancer Center
PTC Therapeutics
Eli Lilly and Company
Baylor College of Medicine
Baylor College of Medicine
National Cancer Institute (NCI)
Valerio Therapeutics
Valerio Therapeutics
Heidelberg University
European Organisation for Research and Treatment of Cancer - EORTC
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute